Follow the Harvard Apparatus Regenerative Technology, Inc. stock price and the full management transaction log of the company, a listed issuer based in United States. Shares are listed on the US market, under the oversight of SEC (Form 4). Market capitalisation: €2.2bn. The latest transaction was filed on 1 December 2025 (Acquisition). Among the most active insiders: He Junli. Every trade is openly available.
14
Insider Decl.
n/a
Thresholds
€158,918
14 ops.
Buy Volume
n/a
n/a
Sell Volume
Analyst consensus: bullish or bearish?
Analysts rate Harvard Apparatus Regenerative Technology, Inc. Strong Buy (bullish), based on 12 analysts. Average price target: US$59.30.
43Σ signal
Buys €158,918n/a Sells
This score ranks the purchase within its own market. No market currently meets the historical allocation criteria, so signals remain watch-only. Not investment advice.
Fundamental score
Ranked 27,923 of 29,057 companies
14.1
score / 100
Value
23
Quality
6
FCF yld-4.0%
Earn yld-5.1%
EV/EBITDA·
ROE-40%
Gross mgn0.0%
Net mgn·
Debt/EBITDA·
Pillars2/3
Transparent value + quality ranking, distinct from the insider signal.
Σ
Sigma AI Analysis
Fundamental view, insider signal, bull and bear case, synthesis.
6,864 shares@ US$4.35100.0% of flowCommon StockSEC:0001493152-23-030013:0
Canonical exit: 19 Nov 2023 (T+90)
14 of 14 declarations
About Harvard Apparatus Regenerative Technology, Inc.
Harvard Apparatus Regenerative Technology, Inc. is a company focused on developing regenerative technologies for medical applications. It aims to create innovative solutions for regenerative medicine.